Ubs Group Ag Milestone Pharmaceuticals Inc. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Ubs Group Ag holds 322,648 shares of MIST stock, worth $535,595. This represents 0.0% of its overall portfolio holdings.
Number of Shares
322,648
Previous 111,523
189.31%
Holding current value
$535,595
Previous $89,000
602.25%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding MIST
# of Institutions
50Shares Held
16.9MCall Options Held
71.8KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$8.25 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.16 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$2.97 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.32 Million1.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$1.89 Million1.67% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $49.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...